Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: A Study of ONO-1110 in Patients With Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ONO-1110 for postherpetic neuralgia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONO-1110

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: ACTIVE_NOT_RECRUITING